Skip to the guide
EXACT 41

Tissue biology / EDUCATIONAL GUIDE

GHK-Cu

GHK-Cu 100 mg box packaging mockup
Packaging mockup
100 mg€39.90

Research aims, observed effects
and the limits of the evidence.

Preclinical evidence focusSources checked 6 September 2026

THE IDEA IN EVERYDAY TERMS

The materials involved in tissue repair

GHK-Cu combines a short peptide with copper. Researchers study how it affects the supporting material around cells, including collagen. Collagen is part of tissue structure, so changes in its production are relevant to understanding wound repair. That is the biological idea behind interest in this compound.

Read the background ↗

Experimental wounds in rats

What has actually been shown?

In the cited rat experiment, GHK-Cu increased collagen and other connective-tissue material inside implanted wound chambers. This measured tissue formation in a specific animal model. It did not test wrinkle reduction, hair growth or injury recovery in people. A result from that model cannot establish that an injectable preparation rejuvenates skin or safely speeds healing.

Read the evidence ↗

01 / OVERVIEW

What is GHK-Cu?

GHK-Cu is a copper complex of the tripeptide glycine-histidine-lysine. It has been investigated in connective-tissue biology. [1]

02 / RESEARCH AIMS

Why it is studied.

Research asks whether it changes extracellular-matrix production during wound repair. The cited experiments used wound chambers in rats. [1]

03 / RESEARCH MAP

Following the research question.

Researchers measured changes in collagen, glycosaminoglycans and associated gene expression. These are tissue-level observations, not proof of systemic rejuvenation. [1]

GHK-Cu research map: Copper–peptide complex; Matrix measurements; Rat wound modelRESEARCH MAP / GHK-CU01Copper–peptide complex02Matrix measurements03Rat wound model
Conceptual research map, not a molecular structure or a proven chain of clinical effects. [1]

04 / OBSERVED EFFECTS

What the evidence shows.

The rat study found increased connective-tissue accumulation in the experimental wound chambers. That does not establish healing efficacy in people. [1]

Study context

Animal experiment

Key distinction

Tissue measurements

Uncertainty

Human transfer uncertain

A selected-source overview, not a systematic review. Research findings are not verified effects of an independently supplied sample.

05 / SAFETY AND LIMITATIONS

Risks belong beside the findings.

FDA notes limited human safety data and immunogenicity concerns for injectable GHK-Cu. [2]

Evidence from a local animal model cannot establish the safety or effects of a different formulation or route.

06 / REFERENCES

Go to the source.

  1. GHK-Cu in rat experimental wounds ↗

    Journal of Clinical Investigation, 1993. Primary animal study.

  2. FDA — Safety concerns for certain compounded substances ↗

    Regulatory safety assessment; route and formulation matter.